Colorado Therapeutics Overview
- Founded
- 2015
- Status
- Private
- Employees
- 11
- Latest Deal Type
- Series A
- Latest Deal Amount
- $2.57M
Colorado Therapeutics General Information
Description
Developer of xenogenic biologic tissue matrix products. The company develops a tissue processing technology that is focused on developing xenogenic biologic tissue matrix products and therapeutic devices for a broad range of soft tissue reinforcement, regenerative and vascular applications.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Primary Office
- 2150 West 6th Avenue
- Unit L
- Broomfield, CO 80020
- United States
+1 (303) 000-0000
Colorado Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 17-Apr-2017 | $2.57M | 00.000 | Completed | Startup | |
| 1. Angel (individual) | 18-Apr-2016 | 00.00 | 00.00 | Completed | Startup |
Colorado Therapeutics Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Joseph Horn | President & Chief Executive Officer | ||
| John Lorbiecki | Chief Operating Officer | ||
| Eric Schauble | Vice President, Corporate Development |
Colorado Therapeutics Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| James Gleeson | Colorado Therapeutics | Board Member | 000 0000 |
| Thomas Raegan | Colorado Therapeutics | Board Member | 000 0000 |
Colorado Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial